Effect of High-Flux Dialysis on Circulating FGF-23 Levels in End-Stage Renal Disease Patients: Results from a Randomized Trial

• Andreas Schneider ,

  * E-mail: schneider_a6@ukw.de

  Affiliation Department of Medicine, Division of Nephrology, University Hospital, Würzburg, Germany

  ⨯
• Markus P. Schneider,

  Affiliation Department of Nephrology and Hypertension, University Hospital, Erlangen-Nürnberg, Germany

  ⨯
• Detlef H. Krieter,

  Affiliation Department of Medicine, Division of Nephrology, University Hospital, Würzburg, Germany

  ⨯
• Bernd Genser,

  Affiliations Mannheim Institute of Public Health, Social and Preventive Medicine, Medical Faculty, Mannheim, Germany, BGStats Consulting, Vienna, Austria

  ⨯
• Hubert Scharnagl,

  Affiliation Medical University of Graz, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Graz, Austria

  ⨯
• Tatjana Stojakovic,

  Affiliation Medical University of Graz, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Graz, Austria

  ⨯
• Christoph Wanner,

  Affiliation Department of Medicine, Division of Nephrology, University Hospital, Würzburg, Germany

  ⨯
• Christiane Drechsler

  Affiliation Department of Medicine, Division of Nephrology, University Hospital, Würzburg, Germany

  ⨯